Yongsheng Buluo

BiotechnologyAngelHuangshan, China

Latest round

Angel

Last raised

Apr 2025

Total raised

Undisclosed

Investors

2

About Yongsheng Buluo

Based in Huangshan, China, and founded in 2024, Yongsheng Buluo is a developer of new immune cell and stem cell drugs. Its core founding team members all come from Tsinghua Bio and Beijing 301 Hospital. Yongsheng Buluo focuses on the research and development of new immune cell and stem cell drugs, and focuses on the development of a universal CAR-NK cell platform targeting solid tumors. It provides gene-edited cell therapy drugs, tumor mRNA vaccines and organ regeneration for cancer patients. The company generates revenue by developing new drugs for immune cells and stem cells. The company will use the fund to build a stem cell laboratory and clinical transformation of the patented CAR-NK immune cell lung cancer treatment technology.

Who invested in Yongsheng Buluo

2 investors across 1 round

See all investors in Yongsheng Buluo

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Apr 15, 2025

    Amount

    Undisclosed

    Investors

    Locked

Questions about Yongsheng Buluo

Who invested in Yongsheng Buluo?

Yongsheng Buluo has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Yongsheng Buluo raised?

Yongsheng Buluo has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Yongsheng Buluo last raise money?

Yongsheng Buluo's most recent round on record is a Angel, in Apr 2025.

What does Yongsheng Buluo do?

Based in Huangshan, China, and founded in 2024, Yongsheng Buluo is a developer of new immune cell and stem cell drugs.

Where is Yongsheng Buluo headquartered?

Yongsheng Buluo is headquartered in Huangshan, China.

Which VCs invest in companies like Yongsheng Buluo?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Yongsheng Buluo's stage. Their profiles are linked below.

Raising like Yongsheng Buluo? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.